Membrane particles generated from mesenchymal stromal cells modulate immune responses by selective targeting of pro-inflammatory monocytes

Mesenchymal stromal cells (MSC) are a promising therapy for immunological disorders. However, culture expanded MSC are large and get trapped in the capillary networks of the lungs after intravenous infusion, where they have a short survival time. Hypothetically, living cells are a risk for tumor for...

Descripción completa

Detalles Bibliográficos
Autores principales: Gonçalves, Fabiany da C., Luk, Franka, Korevaar, Sander S., Bouzid, Rachid, Paz, Ana H., López-Iglesias, Carmen, Baan, Carla C., Merino, Ana, Hoogduijn, Martin J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5608915/
https://www.ncbi.nlm.nih.gov/pubmed/28935974
http://dx.doi.org/10.1038/s41598-017-12121-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5608915/
https://www.ncbi.nlm.nih.gov/pubmed/28935974
http://dx.doi.org/10.1038/s41598-017-12121-z

Ejemplares similares